# Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

> **NCT06790225** · NA · RECRUITING · sponsor: **Esbjerg Hospital - University Hospital of Southern Denmark** · enrollment: 12 (estimated)

## Conditions studied

- Bone Disease, Metabolic
- Diabetes Mellitus, Type 2
- Obesity and Obesity-related Medical Conditions

## Interventions

- **OTHER:** Glucose-dependent Insulinotropic Polypeptide (GIP)

## Key facts

- **NCT ID:** NCT06790225
- **Lead sponsor:** Esbjerg Hospital - University Hospital of Southern Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-10
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-11-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06790225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06790225, "Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06790225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*